MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000142363

Медицинская библиотека · American journal of nephrology · 2008

5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients.

Cianciolo Giuseppe, La Manna Gaetano, Colì Luigi, Donati Gabriele, D'Addio Francesca, Persici Elisa, Comai Giorgia, Wratten Marylou, Dormi Ada, Mantovani Vilma, Grossi Gabriele, Stefoni Sergio

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Hemodialysis (HD) patients have a greatly increased risk of cardiovascular morbidity and mortality. For this reason, attempts are often made to normalize hyperhomocysteinemia. This randomized prospective study sought to determine which risk factors are predictors of mortality and whether high doses of folates or 5-methyltetrahydrofolate (5-MTHF) could improve hyperhomocysteinemia and survival in HD patients.

METHODS

341 patients were divided into two groups: group A was treated with 50 mg i.v. 5-MTHF, and group B was treated with 5 mg/day oral folic acid. Both groups received i.v. vitamin B(6) and B(12). By dividing patients into C-reactive protein (CRP) quartiles, group A had the highest survival for CRP <12 mg/l, whereas no survival difference was found for group B. CRP was the only predictive risk factor for death (RR 1.17, range 1.04-1.30, p = 0.02). Dialysis age, hyperhomocysteinemia, methylenetetrahydrofolate reductase polymorphism, albumin, lipoprotein (a) and folate did not influence mortality risk. Survival in group A was higher than that in group B, namely 36.2 +/- 20.9 vs. 26.1 +/- 22.2 months (p = 0.003).

RESULTS

Our results suggest that CRP, but not hyperhomocysteinemia, is the main risk factor for mortality in HD patients receiving vitamin supplements. Intravenous 5-MTHF seems to improve survival in HD patients independent from homocysteine lowering.

Для цитирования: Cianciolo Giuseppe, La Manna Gaetano, Colì Luigi, Donati Gabriele, D'Addio Francesca, Persici Elisa, Comai Giorgia, Wratten Marylou, Dormi Ada, Mantovani Vilma, Grossi Gabriele, Stefoni Sergio. 5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients.. American journal of nephrology. 2008. DOI: 10.1159/000142363.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.